139 Results
Sort By:
Published on August 16, 2022
The COVID-19 pandemic has really highlighted the need for effective genomic pathogen surveillance and allowed researchers around the world to hone their skills and technology. While these advances are not in doubt, whether they are maintained and used to help prevent new pandemics and fight global threats such as antimicrobial…
Published on August 16, 2022
Artificial intelligence (AI) has the potential to improve many areas of medicine, with drug development as a key focus. Many companies are now working to apply the power of AI to design better drugs, but six companies are leading the race with candidates already in clinical trials. Over the last…
Published on June 15, 2022
Many biologists seek signals of gene expression and study the structure of tissues. Sequencing RNA (RNA-seq) reveals gene expression, and techniques evolved into single-cell RNA-seq (scRNA-seq), which uncovers the gene expression in just one cell. For spatial information about organisms, scientists use microscopy. To put together these two methods, scientists…
Published on June 15, 2022
The COVID-19 pandemic has driven RNA into the public eye and there is increasing recognition of its importance in medicine. The intense scientific drive and the success of mRNA vaccines during the last two years has also benefitted biotech overall, with an increasing list of new RNA startups entering the…
Published on June 15, 2022
Deepak Asudani Deepak Asudani and his two children Ananya and Aarnav have published the first of a series of educational books on DNA and genetics aimed at schoolchildren who are curious to learn about what makes them unique whilst highlighting the similarities we share. Damian Doherty…
Published on April 27, 2022
The COVID-19 pandemic has driven RNA into the public eye and there is increasing recognition of its importance in medicine. The intense scientific drive and the success of mRNA vaccines during the last two years has also benefitted biotech overall, with an increasing list of new RNA startups entering the…
Published on April 20, 2022
A new global coalition of comprising healthcare providers, pharmaceutical companies, diagnostics developers, and researcher organization have provided a blueprint for a new method of how cancer patients are diagnosed and treated around the world. Named the Bloomberg New Economy International Cancer Coalition, the new body demonstrates in a commentary published…
Published on April 8, 2022
By Bruce Quinn Bruce Quinn Decade by decade, healthcare undergoes big changes. But we can still make enormous improvements in innovations for unmet needs, more effective healthcare, better coordinated services, and cost-effectiveness. In particular, this is true in the field of precision medicine, where genomic and…
Published on February 16, 2022
Janice Chen is very inspiring. At the age of 30, she has not only completed a PhD. with recent Nobel prize winner Jennifer Doudna at the University of California, Berkeley, but co-founded Mammoth Biosciences together, where she serves as its CTO. Janice ChenCTO, Mammoth Biosciences Mammoth…
Published on February 16, 2022
We live in an age of wide-reaching population health problems, such as diabetes, cardiovascular disease, and obesity, that have a huge physical, mental, and financial cost for patients and providers. However, new forms of artificial intelligence (AI) could be the answer to solving these population health problems in an efficient…
Published on January 25, 2022
A new COVID-19 diagnostic test developed by researchers at the University of Washington (UW) can detect genetic material from the SARS-CoV-2 virus like PCR-based tests do but, unlike a PCR diagnostic, it can deliver results in as little as 20 minutes. “We designed the test to be low-cost and simple…
Published on December 10, 2021
Janice Chen is very inspiring. At the age of 30, she has not only completed a PhD with Nobel prize winner Jennifer Doudna at the University of California, Berkeley, but she has also helped co-found her own successful biotech company. Jumping straight from finishing her PhD in 2018 to co-founding…
Published on December 1, 2021
About a decade before becoming NIH Director—a position from which he will step down at year’s end—Francis S. Collins, M.D., Ph.D., was at the center of one of the hottest debates in the nascent days of genomics: How many protein-coding sequences comprise the human genome? Collins, then leading the Human…
Published on December 1, 2021
The second year of the COVID-19 pandemic continued to dominate headlines, and the roll out of numerous vaccines in the U.S. and around the world promised to help slow the spread of the virus. Yet despite the disruptions to research and in-person medical care, areas of precision medicine made advances…
Published on October 26, 2021
Mammoth Bioscience’s CRISPR systems technology will be used by Vertex Pharmaceuticals to develop in vivo gene-editing therapies for two undisclosed genetic diseases, in a deal that has the potential to generate as much as $695 million for Mammoth, the two companies announced today. “We are focused on developing in vivo…